C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
By P. Ridker, C. Hennekens, J. Buring, N. Rifai. New England Journal of Medicine, 2000
6,253 citations recorded by the source corpus.
Subfields: Clinical Biochemistry, Epidemiology, Oncology
View Paper: https://www.semanticscholar.org/paper/1079699951213817beb54508400fc4d4084e5972
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Clinical Biochemistry
In Epidemiology
In Oncology
- Peter Libby
- P. Ridker
- B. K. Pedersen
- F. B. Hu
- G. Hansson
- N. Rifai
- Alexander H Sprague
- George Davey Smith
Citations in the corpus
- Effect of Compassion Meditation on Neuroendocrine, Innate Immune and Behavioral Responses to Psychosocial Stress (2008, background): “…increased levels of plasma IL-6 (and/or its downstream product c-reactive protein) predict the development of a number of disease states, including vascular disease, diabetes and dementia (Ridker, 2000; Pradhan et al., 2001; Kiecolt-Glaser et al., 2003; Perry et al., 2007; Steptoe et al., 2007).”
- Elevations of Inflammatory and Procoagulant Biomarkers in Elderly Persons With Renal Insufficiency (2003, methodology): “They were invited to participate in CHS if they met the following inclusion criteria: (1) aged 65 years, (2) not institutionalized, (3) expected to remain in the current community for 3 years, and (4) gave informed consent without requiring a proxy respondent.”
- C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. (2002, background): “Increases in CRP concentration (even when within the clinically normal range) and of other inflammatory markers are independently predictive of future cardiovascular events (1,2).”
- Inflammatory Mechanisms in the Regulation of Insulin Resistance (2008, background): “CRP in most instances is considered as an inflammatory marker related to atherosclerosis and cardiovascular diseases (97,98).”
- Changes in proinflammatory cytokine activity after menopause. (2002, background): “The findings that circulating IL-6 levels predict femoral bone loss in early postmenopausal women (399) and that IL-6-derived C-reactive protein strongly predicts the development of symptomatic coronary artery disease (407) make these measurements attractive parameters for the identification of high”
- Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. (2007, background): “Serum C-reactive protein and other molecular mediators of inflammation have broadened our understanding of the disease by illustrating that peripheral blood can afford valuable prognostic information (3, 4).”
- Adhesion molecules and atherosclerosis. (2003, methodology): “In the setting of primary prevention, hs-CRP has consistently been found to have a strong prognostic utility [85], whereas in patients with documented CAD, sVCAM-1 had apparently superior clinical performance [89].”
- Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. (2004, background): “Examples from other popular journals are Ridker et al. ( 11 ), Zhang et al. (12), Liou et al. (13), and Hogue et al. (14).”